37.75

2.95% 1.08

Zenas Biopharma Inc (ZBIO)

Overview News Price History Discussions Forecast

Zenas Biopharma Inc stock is traded at $37.75, with a volume of 190.95K. It is up +2.95% in the last 24 hours and up +26.04% over the past month. Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.

Previous Close:

$36.67

Open:

$36.62

24h Volume:

190.95K

Relative Volume:

0.47

Market Cap:

$2.03B

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-6.86%

1M Performance:

+26.04%

6M Performance:

+295.29%

1Y Performance:

+283.64%

1-Day Range:

$34.72

$37.98

1-Week Range:

$34.26

$41.00

52-Week Range:

$5.83

$41.00

Zenas Biopharma Inc Stock (ZBIO) Company Profile

Name

Zenas Biopharma Inc

Sector

Healthcare (1131)

Industry

Biotechnology (632)

Phone

857-271-2954

Address

852 WINTER STREET, SUITE 250, WALTHAM

Employee

130

Twitter

Next Earnings Date

Latest SEC Filings

ZBIO's Discussions on Twitter

Compare ZBIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ZBIO Zenas Biopharma Inc	37.75	1.97B	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Zenas Biopharma Inc Stock (ZBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-20-25	Initiated	Wedbush	Outperform
Feb-04-25	Initiated	Wolfe Research	Outperform
Dec-16-24	Initiated	H.C. Wainwright	Buy
Nov-05-24	Initiated	Rodman & Renshaw	Buy
Oct-08-24	Initiated	Citigroup	Buy
Oct-08-24	Initiated	Guggenheim	Buy
Oct-08-24	Initiated	Jefferies	Buy
Oct-08-24	Initiated	Morgan Stanley	Overweight

View All

Zenas Biopharma Inc Stock (ZBIO) Latest News

Dec 04, 2025

2025-12-04 | Bronstein, Gewirtz & Grossman, LLC Encourages Zenas BioPharma, Inc. (ZBIO) Stockholders to Inquire about Securities Investigation | NDAQ:ZBIO | Press Release - Stockhouse

Dec 04, 2025

Dec 03, 2025

Meridian Small Cap Growth Fund Trimmed Zenas BioPharma (ZBIO) Following Share Price Appreciation - Insider Monkey

Dec 03, 2025

Is Zenas BioPharma Inc. stock trading near support levelsQuarterly Trade Report & Low Risk Entry Point Guides - Newser

Dec 03, 2025

Nov 30, 2025

Did You Lose Money on Zenas BioPharma, Inc. (ZBIO)? Levi & Korsinsky Urges Investors to Act Before June 16, 2025 - The National Law Review

Nov 30, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Nov 30, 2025

Securities Lawsuit Alert: Zenas BioPharma, Inc. (ZBIO)Contact Levi & Korsinsky Before June 16, 2025 - The National Law Review

Nov 30, 2025

Nov 29, 2025

ZBIO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review

Nov 29, 2025

EV Market: How interest rate cuts could boost Zenas BioPharma Inc. stockWeekly Loss Report & Reliable Breakout Stock Forecasts - BỘ NỘI VỤ

Nov 29, 2025

Zenas BioPharma (NASDAQ:ZBIO) Stock Price Down 3.5%Here's What Happened - MarketBeat

Nov 29, 2025

Update Report: Can Zenas BioPharma Inc. stock reach $100 price targetJuly 2025 Levels & Weekly Breakout Opportunity Watchlist - moha.gov.vn

Nov 29, 2025

Nov 28, 2025

Zenas BioPharma Reports Q3 2025 Financial Results - MSN

Nov 28, 2025

How interest rate cuts could boost Zenas BioPharma Inc. stockWeekly Trade Summary & Real-Time Market Sentiment Reports - BỘ NỘI VỤ

Nov 28, 2025

Evercore ISI Initiates Coverage on Zenas BioPharma (NASDAQ:ZBIO) - Defense World

Nov 28, 2025

Nov 27, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Stockholders to Reach Out - ACCESS Newswire

Nov 27, 2025

Nov 26, 2025

Can Zenas BioPharma's (ZBIO) Improving Loss Per Share Shift Investor Confidence in Its Long-Term Story? - simplywall.st

Nov 26, 2025

Nov 25, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Zenas BioPharma, Inc. (ZBIO) And Encourages Stockholders to Connect - ACCESS Newswire

Nov 25, 2025

Zenas Biopharma stock hits all-time high at 38.92 USD By Investing.com - Investing.com Australia

Nov 25, 2025

Zenas Biopharma stock hits all-time high at 38.92 USD - Investing.com

Nov 25, 2025

Nov 24, 2025

IgG4-related disease Market Size was USD 170 million in 2024, - openPR.com

Nov 24, 2025

Nov 23, 2025